Skip Navigation
 
 
 
 xxx
 
Print This Page
Share this page: More
 

Preventing HPV and Cervical Disease

Prophylactic vaccines

There are two commercially available vaccines that help protect adolescents and women from HPV: Gardisil and Cervarix. Gardasil, administered in three injections over six months, is recommended for 11- and 12-year-old girls, or for females aged 13 through 26 who have not yet been vaccinated or completed the vaccine series. This vaccine targets the types of HPV that most commonly cause cervical cancer (16 and 18), as well as the two strains of HPV that most commonly cause genital warts (6 and 11). Cervarix, which is FDA-approved for females aged 10 to 25, also is administered in a series of three shots and protects against two strains of HPV (16 and 18) that cause cervical cancer. Ideally, females should get the vaccine before they become sexually active, when they may be exposed to HPV.

These vaccines do not protect against all types of HPV; about 30 percent of cervical cancers will not be prevented by the vaccine. The vaccines also do not protect against other sexually transmitted infections, and cannot treat existing HPV. Therefore, it is still important for those who get the vaccines to continue regular screenings for cervical cancer through gynecological checkups and Pap tests.

Pap tests

Regular gynecological checkups, including a pelvic exam and Pap tests (link to above descriptions), will help detect any abnormal changes to the cervix as early as possible.

 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5222
U.S. 410-955-5222
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer